Hinge Health, Inc.

Hinge Health, Inc.

HNGE·NYSE

$58.66

+6.6%
HealthcareMedical - Healthcare Information Services

Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.

At a Glance

Live Snapshot
Market Cap$4.54B
EPS-5.3600
P/E Ratio-6.96
Earnings Date08/04/2026

hnge

Research Development Expenses

Last Annual Value

368.14M

3-Year CAGR

50%

5-Year CAGR

27%

10-Year CAGR

13%

Hinge Health, Inc.

Hinge Health, Inc. Competitors Analysis of research-development-expenses

HNGE · NYSE
Companyresearch-development-expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
368.14M
49.6%N/AN/A 
177.31M
31.7%31.6%30.7%
344.95M
75.5%50.3%44.0%
247.50M
20.4%24.8%N/A
IMVT logo
Immunovant, Inc.
NASDAQ:IMVT
456.66M
41.8%46.1%N/A
398.33M
23.6%26.8%N/A
267.12M
45.5%17.3%N/A
97.00M
-5.8%13.3%-1.2%
72.03M
7.3%-7.3%N/A
332.06M
25.4%31.6%51.8%
0.00
N/AN/AN/A
Hinge Health, Inc.

Hinge Health, Inc. Fair Value Envelope

HNGE · NYSE

Our analysis suggests that HNGE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $58.66, this represents a potential HIDDEN relative to our calculated worth for Hinge Health, Inc..

Intrinsic Value
Current Price: $58.66